Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Given Consensus Recommendation of “Moderate Buy” by Brokerages
Sarepta Therapeutics, Inc. (NASDAQ:SRPT – Get Free Report) has received a consensus rating of “Moderate Buy” from the nineteen research firms that are covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation, sixteen have given a buy recommendation and one has issued a strong buy recommendation […]
More Stories
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO) Sees Significant Growth in Short Interest
NeuroBo Pharmaceuticals, Inc. (NASDAQ:NRBO – Get Free Report) was the recipient of a large increase in short interest in the...
Two Harbors Investment Corp. (NYSE:TWO) Short Interest Up 17.5% in September
Two Harbors Investment Corp. (NYSE:TWO – Get Free Report) saw a significant increase in short interest in September. As of...
World News in Brief: Possible ‘dire consequences’ for Yemen following strikes, Ukraine hospital attack, human rights in Algeria
UN humanitarians on Monday warned of the potentially dire consequences that could arise from disruption to the flow of food...
QUALCOMM Incorporated (NASDAQ:QCOM) Given Consensus Recommendation of “Moderate Buy” by Brokerages
QUALCOMM Incorporated (NASDAQ:QCOM – Get Free Report) has been assigned an average recommendation of “Moderate Buy” from the twenty-six ratings...
PepsiCo, Inc. (NASDAQ:PEP) Receives $185.53 Consensus Price Target from Brokerages
PepsiCo, Inc. (NASDAQ:PEP – Get Free Report) has been assigned an average recommendation of “Hold” from the fourteen brokerages that...
PayPal Holdings, Inc. (NASDAQ:PYPL) Given Average Recommendation of “Moderate Buy” by Brokerages
Shares of PayPal Holdings, Inc. (NASDAQ:PYPL – Get Free Report) have received a consensus rating of “Moderate Buy” from the...